Literature DB >> 12165664

Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques.

Nobue Kumaki1, Hiroshi Kajiwara, Kaori Kameyama, Ronald A DeLellis, Sylvia L Asa, R Yoshiyuki Osamura, Hiroshi Takami.   

Abstract

Pheochromocytomas and paragangliomas arise from the adrenal glands and extraadrenal paraganglia, respectively. Malignant behavior of these tumors is uncommon and is, in part, dependent on their sites of origin, such as extraadrenal location. Morphologic criteria for malignancy of pheochromocytoma and paragangliomas have not been clearly defined. In this study, to clarify the histologic features that distinguish the benign from malignant pheochromocytomas and paragangliomas, we examined metastatic and nonmetastatic tumors using immunohistochemical techniques. A total of eight cases, five pheochromocytomas from the adrenal glands (four benign and one malignant tumor) and three paragangliomas with invasion or metastasis, were studied. The markers used in this study were chromogranin A, synaptophysin, NCAM (CD56), SNAP25, neuron-specific enolase, S-100 protein, and MIB-1. Our results suggest that MIB-1 immunostaining is a useful adjunct marker to predict malignant behavior in these tumors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12165664     DOI: 10.1385/ep:13:2:149

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  20 in total

1.  Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones.

Authors:  N Kimura; W Miura; T Noshiro; K Mizunashi; K Hanew; K Shimizu; T Watanabe; S Shibukawa; H E Sohn; K Abe; Y Miura; H Nagura
Journal:  Endocr J       Date:  1997-04       Impact factor: 2.349

2.  Expression and prognostic value of c-erbB-2 oncogene product in human phaeochromocytomas.

Authors:  L Castilla-Guerra; A M Moreno; M C Fernández-Moreno; J C Utrilla; E Fernández; H Galera-Davison
Journal:  Histopathology       Date:  1997-08       Impact factor: 5.087

3.  Prognostic value of p53, bcl-2, and c-erbB-2 protein expression in phaeochromocytomas.

Authors:  R R de Krijger; E van der Harst; F van der Ham; T Stijnen; W N Dinjens; J W Koper; H A Bruining; S W Lamberts; F T Bosman
Journal:  J Pathol       Date:  1999-05       Impact factor: 7.996

4.  Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies.

Authors:  G M Portel-Gomes; L Grimelius; H Johansson; E Wilander; M Stridsberg
Journal:  Am J Surg Pathol       Date:  2001-10       Impact factor: 6.394

5.  S100 protein-positive sustentacular cells in malignant and locally aggressive adrenal pheochromocytomas.

Authors:  P Unger; K Hoffman; D Pertsemlidis; S Thung; D Wolfe; M Kaneko
Journal:  Arch Pathol Lab Med       Date:  1991-05       Impact factor: 5.534

6.  Pheochromocytomas: can malignant potential be predicted?

Authors:  H John; W H Ziegler; D Hauri; P Jaeger
Journal:  Urology       Date:  1999-04       Impact factor: 2.649

7.  Malignant pheochromocytoma. Chromaffin granule transmitters and response to treatment.

Authors:  F Rao; H R Keiser; D T O'Connor
Journal:  Hypertension       Date:  2000-12       Impact factor: 10.190

8.  Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation: A positive correlation between MIB-1 staining and malignant tumor behavior.

Authors:  H M Brown; R A Komorowski; S D Wilson; M J Demeure; Y R Zhu
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

9.  Proliferative index in phaeochromocytomas: does it predict the occurrence of metastases?

Authors:  E van der Harst; H A Bruining; H Jaap Bonjer; F van der Ham; W N Dinjens; S W Lamberts; W W de Herder; J W Koper; T Stijnen; C Proye; M Lecomte-Houcke; F T Bosman; R R de Krijger
Journal:  J Pathol       Date:  2000-06       Impact factor: 7.996

10.  Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues.

Authors:  R V Lloyd; M Blaivas; B S Wilson
Journal:  Arch Pathol Lab Med       Date:  1985-07       Impact factor: 5.534

View more
  11 in total

1.  Difficult cases of thyroid pathology.

Authors:  Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 2.  Endocrine pathology in translational medicine: an overview of current and future prospects.

Authors:  Robert Yoshiyuki Osamura; Nobue Kumaki; Hiroshi Kajiwara; Noboru Egashira; Syunsuke Miyai; Susumu Takekoshi; Masanori Yasuda; Shinobu Umemura
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 3.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 4.  [Dignity of carotid body tumors. Review of the literature and clinical experiences].

Authors:  D Grotemeyer; S M Loghmanieh; S Pourhassan; T A Sagban; F Iskandar; P Reinecke; W Sandmann
Journal:  Chirurg       Date:  2009-09       Impact factor: 0.955

5.  Triple-way therapeutic approach for paraganglioma-dependent erythrocytosis: drugs and surgery plus "multi-manner" apheresis.

Authors:  M Todorovic; B Balint; N Suvajdzic; M Jevtic; M Pavlovic; M Petrovic; M Krstic; V Popovic; B Ivanovic; I Elezovic; R Milenkovic; M Colovic
Journal:  Med Oncol       Date:  2007-09-25       Impact factor: 3.064

Review 6.  Old, New, and Emerging Immunohistochemical Markers in Pheochromocytoma and Paraganglioma.

Authors:  Veronica K Y Cheung; Anthony J Gill; Angela Chou
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

Review 7.  Histopathology and immunohistochemistry of adrenal medullary tumors and paragangliomas.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2006       Impact factor: 3.943

8.  Paragangliomas and paraganglioma syndromes.

Authors:  Carsten Christof Boedeker
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

9.  Pheochromocytoma in an accessory adrenal gland: a case report.

Authors:  Oludolapo Afuwape; Josephus K Ladipo; Olabiyi Ogun; Jokotade Adeleye; David Irabor
Journal:  Cases J       Date:  2009-08-03

10.  Bilateral carotid paraganglioma: surgery and radiotherapy.

Authors:  Huriye S Kiziltan; Berke Ozucer; Ali H Eris; Bayram Veyseller
Journal:  Clin Med Insights Case Rep       Date:  2014-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.